Cargando…

Adjuvant Treatment in Pancreatic Cancer: Shaping the Future of the Curative Setting

Pancreatic ductal adenocarcinoma (PDAC) is a lethal disease even in the early stages, despite progresses in surgical and pharmacological treatment in recent years. High potential for metastases is the main cause of therapeutic failure in localized disease, highlighting the current limited knowledge...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pappalardo, Annalisa, Giunta, Emilio Francesco, Tirino, Giuseppe, Pompella, Luca, Federico, Piera, Daniele, Bruno, De Vita, Ferdinando, Petrillo, Angelica
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8415474/ https://www.ncbi.nlm.nih.gov/pubmed/34485130 http://dx.doi.org/10.3389/fonc.2021.695627

Ejemplares similares

What’s New in Gastric Cancer: The Therapeutic Implications of Molecular Classifications and Future Perspectives
por: Tirino, Giuseppe, et al.
Publicado: (2018)

Perioperative Treatment in Resectable Gastric Cancer: Current Perspectives and Future Directions
por: Petrillo, Angelica, et al.
Publicado: (2019)

Pancreatic Cancer Molecular Classifications: From Bulk Genomics to Single Cell Analysis
por: Pompella, Luca, et al.
Publicado: (2020)

Durable Complete Radiological Response to Nivolumab in Two Heavily Pretreated Western Elderly Patients With Metastatic Gastric Cancer: A Case Report
por: Tirino, Giuseppe, et al.
Publicado: (2020)

How to Treat Hepatocellular Carcinoma in Elderly Patients
por: Federico, Piera, et al.
Publicado: (2021)

Nivolumab in Heavily Pretreated Metastatic Gastric Cancer Patients: Real-Life Data from a Western Population
por: Petrillo, Angelica, et al.
Publicado: (2020)

Resistance to Antiangiogenic Therapy in Hepatocellular Carcinoma: From Molecular Mechanisms to Clinical Impact
por: Federico, Piera, et al.
Publicado: (2022)

Bone Metastases from Gastric Cancer: What We Know and How to Deal with Them
por: Petrillo, Angelica, et al.
Publicado: (2021)

Novel Therapeutic Opportunities in Neoadjuvant Setting in Urothelial Cancers: A New Horizon Opened by Molecular Classification and Immune Checkpoint Inhibitors
por: Iacovino, Maria Lucia, et al.
Publicado: (2022)

Naples Prognostic Score Predicts Tumor Regression Grade in Resectable Gastric Cancer Treated with Preoperative Chemotherapy
por: Lieto, Eva, et al.
Publicado: (2021)

Neutrophil to Lymphocyte Ratio as a Predictor of Poor Prognosis in Metastatic Pancreatic Cancer Patients Treated with Nab-Paclitaxel plus Gemcitabine: A Propensity Score Analysis
por: Ventriglia, J., et al.
Publicado: (2018)

Epigenetic Regulation in Melanoma: Facts and Hopes
por: Giunta, Emilio Francesco, et al.
Publicado: (2021)

Enhanced Antitumor Effect of Trastuzumab and Duligotuzumab or Ipatasertib Combination in HER-2 Positive Gastric Cancer Cells
por: Laterza, Maria Maddalena, et al.
Publicado: (2021)

Clinical implications of dihydropyrimidine dehydrogenase expression in patients with pancreatic cancer who undergo curative resection with S-1 adjuvant chemotherapy
por: Murakawa, Masaaki, et al.
Publicado: (2017)

An Australasian perspective on the curative treatment of patients with pancreatic cancer, supportive care, and future directions for management
por: Muircroft, Wendy
Publicado: (2016)

Diphenyl Dimethyl Bicarboxylate in the Treatment of Viral Hepatitis, Adjuvant or Curative?
por: Wang, Chen, et al.
Publicado: (2008)

Adjuvant atezolizumab-bevacizumab after curative therapy for hepatocellular carcinoma
por: Kudo, Masatoshi
Publicado: (2023)

Hepatitis B: future curative strategies
por: Bertoletti, Antonio, et al.
Publicado: (2014)

Gemcitabine/Nab-Paclitaxel versus FOLFIRINOX in Locally Advanced Pancreatic Cancer: A European Multicenter Study
por: Williet, Nicolas, et al.
Publicado: (2021)

Cost-effectiveness of adjuvant chemotherapy for curatively resected gastric cancer with S-1
por: Hisashige, Akinori, et al.
Publicado: (2013)

Adjuvant chemotherapy in curatively resected rectal cancer: How valid are the data?
por: Manzini, Giulia, et al.
Publicado: (2020)

The Gene Set Builder: collation, curation, and distribution of sets of genes
por: Yusuf, Dimas, et al.
Publicado: (2005)

A pancreatic pseudopapillary tumor enucleated curatively
por: Karakas, Serdar, et al.
Publicado: (2015)

Predictive role of human equilibrative nucleoside transporter 1 in patients with pancreatic cancer treated by curative resection and gemcitabine-only adjuvant chemotherapy
por: Aoyama, Toru, et al.
Publicado: (2017)

NAB-paclitaxel and gemcitabine in metastatic pancreatic ductal adenocarcinoma (PDAC): from clinical trials to clinical practice
por: De Vita, Ferdinando, et al.
Publicado: (2016)

Beyond the Guidelines: The Grey Zones of the Management of Gastric Cancer. Consensus Statements from the Gastric Cancer Italian Network (GAIN)
por: Fornaro, Lorenzo, et al.
Publicado: (2021)

Impact of Adjuvant Chemotherapy in Patients With Curatively Resected Stage IV Colorectal Cancer
por: Kobayashi, Hirotoshi, et al.
Publicado: (2015)

Adjuvant transarterial chemoembolization to improve the prognosis of hepatocellular carcinoma following curative resection
por: Kuang, Xuejun, et al.
Publicado: (2018)

Adjuvant therapies after curative treatments for hepatocellular carcinoma: Current status and prospects
por: Zhu, Xiao-Dong, et al.
Publicado: (2020)

Adjuvant therapy following curative treatments for hepatocellular carcinoma: current dilemmas and prospects
por: Guo, Bin, et al.
Publicado: (2023)

Clinical implications of ribonucleotide reductase subunit M1 in patients with pancreatic cancer who undergo curative resection followed by adjuvant chemotherapy with gemcitabine
por: Aoyama, Toru, et al.
Publicado: (2017)

Pattern of recurrence and overall survival in esophagogastric cancer after perioperative FLOT and clinical outcomes in MSI-H population: the PROSECCO Study
por: Nappo, Floriana, et al.
Publicado: (2023)

Grand Challenge in Psychopharmacology: Setting Priorities to Shape a Bright Future
por: Ciccocioppo, Roberto
Publicado: (2017)

Simultaneous curative resection of double colorectal carcinoma with synchronous bilobar liver metastases
por: De Raffele, Emilio, et al.
Publicado: (2018)

Efficacy of Surgery for the Treatment of Gastric Cancer Liver Metastases: A Systematic Review of the Literature and Meta-Analysis of Prognostic Factors
por: Marte, Gianpaolo, et al.
Publicado: (2021)

Analysis of the Curative Effect of Neoadjuvant Therapy on Pancreatic Cancer
por: Yang, Liqiong, et al.
Publicado: (2021)

Curating gene sets: challenges and opportunities for integrative analysis
por: Bubier, Jason, et al.
Publicado: (2019)

Results of the observational prospective RealFLOT study
por: Giommoni, Elisa, et al.
Publicado: (2021)

Potential Impact of Phellinus linteus on Adherence to Adjuvant Treatment After Curative Resection of Pancreatic Ductal Adenocarcinoma: Outcomes of a Propensity Score–Matched Analysis
por: Lee, Sung Hwan, et al.
Publicado: (2018)

Adjuvant Gemcitabine-Oxaliplatin (GEMOX) after Curative Surgery in High-risk Patients with Cholangiocarcinoma
por: Paule, Bernard, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_amh7q972laqpnuer9coi2im3df